James Scanlon

13 papers receiving 1.4k citations

James Scanlon's Hit Papers

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy 2012 · 912 citations
9120+4+9Years since publication250500750

Peers

James Scanlon
Comparison fields: 5 of 83
  • Pathology and Forensic Medicine 461
  • Oncology 518
  • Endocrinology, Diabetes and Metabolism 315
  • Immunology 193
  • Neurology 119
Replace Gary Bloomgren with:
Gary Bloomgren United States
Christian Klemann Germany
Ahmad Al‐Sabbagh United States
JC Lee United States
John L. Clayton United States
Marina Afanasyeva United States
Bernadette Hennache France
E Möller Sweden
László Pajor Hungary
Daniela Adriana Ion Romania
James Scanlon relative to Gary Bloomgren United States Gary Bloomgren's profile →
Citations per field
00.5×1.5×2.5×
Gary Bloomgren · 1×
Citations per year

Countries citing papers authored by James Scanlon

Since Specialization
Citations

This map shows the geographic impact of James Scanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Scanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Scanlon more than expected).

Fields of papers citing papers by James Scanlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Scanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Scanlon. The network helps show where James Scanlon may publish in the future.

Co-authors

The 25 scholars most cited alongside James Scanlon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Scanlon Line = papers co-authored together James Scanlon links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Hit paper breakdown →
2012912
2 2009345
3 2011107
4 201249
5 200922
6 200916
7 201012
8 202110
9 20218
10 20128
11
Decayed,Missing,And filled teeth among children, United States.
19746
12 19753
13 19782
14
Self-Reported Health Behavior and Attitudes of Youths 12-17 Years, United States. Data from the National Health Survey, Series 11, Number 147.
19751

About James Scanlon

James Scanlon is a scholar working on Oncology, Pathology and Forensic Medicine, General Health Professions, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Polyomavirus and related diseases (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Migraine and Headache Studies (2 papers), Diabetes Management and Research (1 paper), Sympathectomy and Hyperhidrosis Treatments (1 paper), Criminal Justice and Corrections Analysis (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Dental Health and Care Utilization (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (461 citations), Oncology (518 citations), Endocrinology, Diabetes and Metabolism (315 citations), Immunology (193 citations) and Neurology (119 citations). James Scanlon has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Carmen Bozic, Sandra Richman, Alfred Sandrock, Tatiana Plavina, Gary Bloomgren, Meena Subramanyam, Christophe Hotermans, Susan Goelz, Sophia Lee and Michael E. Matheny. Their work appears in journals such as Headache The Journal of Head and Face Pain, Annals of Pharmacotherapy, Diabetes Care, Journal of the Neurological Sciences and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact